Katharine Knobil, M.D.
Board Member
Korro Bio, Inc. (KRRO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Katharine Knobil, M.D.
Katharine Knobil, M.D. is recorded as Board Member at Korro Bio, Inc. (KRRO). Korro Bio, Inc. reported in an 8-K filed August 28, 2024 that Katharine Knobil, M.D. was appointed Class III director on the Board, effective August 26, 2024.
“the Board, reduced the number of directors from seven to six to eliminate the vacancy in Class I resulting from Mr. Lucchino's resignation; and then increased the number of directors from six to seven to create a vacancy in Class III and then appointed Katharine Knobil, M.D. to fill the newly created vacancy on the Board in Class III effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-08-26–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Korro Bio, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher Loose CEO
- David L. Lucchino CEO, Board Member
- Ram Aiyar CEO, CFO, Board Member
- Nessan Bermingham Chairman, Board Member
- Peter P. Pfreundschuh CFO
- Richard M. Mitrano CFO, Chief Accounting Officer
- Vineet Agarwal CFO
- Todd Chappell COO
- Steve Colletti CTO
- Jeffrey Cerio General Counsel
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.